AMST Plummets 32% After Announcing $6M Concurrent Direct Offering, Private Placement

• Amesite also stated that it has agreed to issue Series A-1 and Series A-2 warrants to purchase an additional 1.4 million shares of its common stock at an exercise price of $1.435 per share.
• In addition to the direct offering, Amesite also announced that it has entered into definitive agreements for a private placement of its common stock.
• This includes 696,866 shares and up to 1.4 million warrants, both priced at $1.435 per share.

Shares of Amesite Inc. (AMST) fell more than 32% on Monday before paring some of the losses after the company announced a direct offering of its common stock.

Amesite stated that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock at a price of $1.435 per share. This is at a discount of more than 9% to Amesite’s closing price on Friday.

Amesite shares were down nearly 25% in Monday’s midday trade.

Amesite Issues Warrants For 1.4 Million Additional Shares

Amesite also stated that it has agreed to issue Series A-1 and Series A-2 warrants to purchase an additional 1.4 million shares of its common stock.

These warrants have an exercise price of $1.435 per share and will be exercisable on the effective date of shareholder approval.

The Series A-1 warrants will expire five years after the later of the Resale Registration Statement’s effective date or stockholder approval, while the Series A-2 warrants will expire 18 months after the later of those same two dates.

In addition to the direct offering, Amesite also announced that it has entered into definitive agreements for a private placement of its common stock. This includes 696,866 shares and up to 1.4 million warrants, both priced at $1.435 per share.

Amesite stated that the offerings are expected to close on or about April 28, 2026. The company expects gross proceeds of up to $2 million from the direct offering. The potential gross proceeds from the warrants, if fully exercised, will be approximately $4 million.

Amesite intends to use the proceeds of the offering to meet its working capital requirements and for other general corporate purposes.

The company also announced the withdrawal of its public offering.

What Does Amesite Do?

Amesite is a Detroit-based AI-driven company behind the NurseMagic platform, which streamlines documentation for nurses and caregivers.

The company touts that NurseMagic can reduce the documentation process from 20 minutes to 20 seconds. It added that the platform is used across more than 100 professions, serving users across 50 states and 21 countries.

How Did Retail Traders React?

Retail sentiment on Stocktwits around Amesite trended in the ‘bullish’ territory, with message volumes at ‘extremely high’ levels at the time of writing.

One user stated that the selloff in Amesite stock makes them want to invest more in the company.

AMST stock is down 36% year-to-date and 43% over the past 12 months. The Vanguard Extended Market Index Fund ETF (VXF) is up 33% over the past 12 months.

Also See: ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94%

For updates and corrections, email newsroom[at]stocktwits[dot]com.